Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL - PubMed (original) (raw)
. 1996 Sep 13;271(37):22764-72.
doi: 10.1074/jbc.271.37.22764.
Affiliations
- PMID: 8798452
- DOI: 10.1074/jbc.271.37.22764
Free article
Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL
P L Simonian et al. J Biol Chem. 1996.
Free article
Abstract
Bax, a member of the Bcl-2 family of proteins, has been shown to promote apoptosis while other members of the family, including Bcl-XL and Bcl-2, inhibit cell death induced by a variety of stimuli. The mechanism by which Bax promotes cell death is poorly understood. In the present report, we assessed the ability of Bax to antagonize the death repressor activity of Bcl-XL during chemotherapy-induced apoptosis in the lymphoid cell line, FL5.12. Expression of wild-type Bax countered the repressor activity of Bcl-XL against cell death mediated by VP-16 and cisplatin. We performed site-directed mutagenesis of the BH1, BH2, and BH3 homology regions in Bax to determine the ability of wild-type and mutant Bax to heterodimerize with Bcl-XL and to antagonize the protective effect of Bcl-XL against chemotherapy-induced apoptosis. Bax proteins expressing alanine substitutions of the highly conserved amino acids glycine 108 in BH1, tryptophan 151 and 158 in BH2, and glycine 67 and aspartic acid 68 in BH3 retained their ability to promote chemotherapy-induced cell death that was inhibited by Bcl-XL and to form heterodimers with Bcl-XL. Bax proteins containing deletions of the most highly conserved amino acids in BH1 (Delta102-112) and BH2 (Delta151-159) maintained the ability of Bax to antagonize the death repressor activity of Bcl-XL and to associate with Bcl-XL. However, Bax with BH3 deleted did not form heterodimers with Bcl-XL, but retained its ability to counter the death repressor activity of Bcl-XL. These results demonstrate that the conserved BH3, but not BH1 or BH2, homology region of Bax is necessary for its interaction with Bcl-XL in mammalian cells. Furthermore, our results indicate that Bax does not require BH1, BH2, BH3, or heterodimerization with Bcl-XL to counter the death repressor activity of Bcl-XL. Therefore, Bax can antagonize Bcl-XL during VP-16 and, in a lesser degree, during cisplatin-induced cell death independent of its heterodimerization with Bcl-XL.
Similar articles
- Bax homodimerization is not required for Bax to accelerate chemotherapy-induced cell death.
Simonian PL, Grillot DA, Andrews DW, Leber B, Nuñez G. Simonian PL, et al. J Biol Chem. 1996 Dec 13;271(50):32073-7. doi: 10.1074/jbc.271.50.32073. J Biol Chem. 1996. PMID: 8943258 - Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2.
Zha H, Aimé-Sempé C, Sato T, Reed JC. Zha H, et al. J Biol Chem. 1996 Mar 29;271(13):7440-4. doi: 10.1074/jbc.271.13.7440. J Biol Chem. 1996. PMID: 8631771 - Bak can accelerate chemotherapy-induced cell death independently of its heterodimerization with Bcl-XL and Bcl-2.
Simonian PL, Grillot DA, Nuñez G. Simonian PL, et al. Oncogene. 1997 Oct 9;15(15):1871-5. doi: 10.1038/sj.onc.1201350. Oncogene. 1997. PMID: 9362454 - Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death.
Reed JC, Zha H, Aime-Sempe C, Takayama S, Wang HG. Reed JC, et al. Adv Exp Med Biol. 1996;406:99-112. Adv Exp Med Biol. 1996. PMID: 8910675 Review. - Role of the BH3 (Bcl-2 homology 3) domain in the regulation of apoptosis and Bcl-2-related proteins.
Lutz RJ. Lutz RJ. Biochem Soc Trans. 2000 Feb;28(2):51-6. doi: 10.1042/bst0280051. Biochem Soc Trans. 2000. PMID: 10816098 Review.
Cited by
- Trifluoperazine, an Antipsychotic Drug, Effectively Reduces Drug Resistance in Cisplatin-Resistant Urothelial Carcinoma Cells via Suppressing Bcl-xL: An In Vitro and In Vivo Study.
Kuo KL, Liu SH, Lin WC, Hsu FS, Chow PM, Chang YW, Yang SP, Shi CS, Hsu CH, Liao SM, Chang HC, Huang KH. Kuo KL, et al. Int J Mol Sci. 2019 Jun 30;20(13):3218. doi: 10.3390/ijms20133218. Int J Mol Sci. 2019. PMID: 31262032 Free PMC article. - Distinct functional domains of PNMA5 mediate protein-protein interaction, nuclear localization, and apoptosis signaling in human cancer cells.
Lee YH, Pang SW, Poh CL, Tan KO. Lee YH, et al. J Cancer Res Clin Oncol. 2016 Sep;142(9):1967-77. doi: 10.1007/s00432-016-2205-5. Epub 2016 Jul 16. J Cancer Res Clin Oncol. 2016. PMID: 27424190 - Prognostic role of sensitive-to-apoptosis gene expression in rectal cancer.
Ozden SA, Ozyurt H, Ozgen Z, Kilinc O, Oncel M, Gul AE, Karadayi N, Serakinci N, Kan B, Orun O. Ozden SA, et al. World J Gastroenterol. 2011 Nov 28;17(44):4905-10. doi: 10.3748/wjg.v17.i44.4905. World J Gastroenterol. 2011. PMID: 22171132 Free PMC article. - The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells.
Jin KL, Park JY, Noh EJ, Hoe KL, Lee JH, Kim JH, Nam JH. Jin KL, et al. J Gynecol Oncol. 2010 Dec 30;21(4):262-8. doi: 10.3802/jgo.2010.21.4.262. Epub 2010 Dec 31. J Gynecol Oncol. 2010. PMID: 21278889 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials